Skip mediastinal nodal metastases in the IIIA/N2 non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 2, Issue 11, 2007, Pages 1018-1021

  Ilic, Nenad ^a   Petricevic, Ante ^a   Arar, Dragan ^a   Kotarac, Slavica ^a   Banovic, Josip ^a   Ilic, Nives Frleta ^a   Tripkovic, Andro ^a   Grandic, Leo ^a  

^a University Surgical Hospital   (Croatia)

Author keywords

N2 disease; Non small cell lung cancer; Skip mediastinal metastases; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 35848945663     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318158d471     Document Type: Article

References (18)

1. Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol 2006;1:4:281-286.
2. Takayuki F, Shoichi M, Kohei Y, Tetsuya M. Significance of number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 2006;2:120-125.
3. Oosterhuis JWA, Theunissen PHMH, Bollen ECM. Improved preoperative staging in non-small cell lung cancer by serial sectioning and immunohistochemical staining of lymph-node biopsy. Eur J Cardiothorac Surg 2001;20:335-338.
4. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg 1999;16:S17-S24.
5. Tsubota N, Yoshimura M. Skip metastases and hidden N2 disease in lung cancer; how successful is mediastinal dissection? Surg Today 1996;26:169-172.
6. Andre F, Gunenwald D, Pignon JP, Dujon A, Pujol JL, Brichon PY. Survival of patients with resected N2 non-small cell lung cancer: evidence of subclassification and implications. J Clin Oncol 2000;18: 2981-2989.
7. Nakamishi R, Osaki T, Nakanishi K, et al. Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer. Ann Thorac Surg 1997;64:342-348.
8. Tanaka F, Yanagihara K, Otake Y, et al. Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastases classification and its time trend. Eur J Cardiothoracic Surg 2000;18:147-155.
9. GCCB-S (Grupo Cooperativo de Carcinoma Bronchogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica). Intraoperative lymph node staging in bronchogenic carcinoma surgery. Consensus report. Arch Bronchopneumol 2001;37:459-503.
10. Izbicki JR, Passlick B, Hosch SB, et al. Mode of spread in the early phase of lymphatic metastasis in non-small cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 1996;112:623-630.
11. Yoshino I, Yokoyama H, Yano T, et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 1996;62:1021-1025.
12. Yano T, Fukuyama Y, Yokoyama H, et al. Long term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection. Eur J Cardiothorac Surg 1998;14:152-155.
13. Gunluoglu Z, Solak O, Metin M, Gurses A. The prognostic significance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer. Eur J Cardiothorac Surg 2002;21:595.
14. Prenzel KL, Monig SP, Sinning JM, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol 2003;82:256-260.
15. Sagawa M, Sakurada A, Fujimura S, et al. Five year survivors with resected pN2 non-small cell lung cancer. Cancer 1999;85:864-868.
16. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710-1717.
17. Misthos P, Sepsas E, Athanassiadi K, et al. Skip metastases: Analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg 2004;25:502-508.
18. Riquet M, Assouad J, Bagan P, et al. Skip mediastinal lymph node metastasis and lung cancer. A particular N2 subgroup with a better prognosis. Ann Thorac Surg 2006;128:130-137.